Reviewing PetMed Express (NASDAQ:PETS) and Globavend (NASDAQ:GVH)

PetMed Express (NASDAQ:PETS) and Globavend (NASDAQ:GVH) are both small-cap retail/wholesale companies, but which is the superior stock? We will compare the two companies based on the strength of their earnings, analyst recommendations, institutional ownership, risk, valuation, profitability and dividends.

Risk & Volatility

PetMed Express has a beta of 0.77, suggesting that its stock price is 23% less volatile than the S&P 500. Comparatively, Globavend has a beta of 3.76, suggesting that its stock price is 276% more volatile than the S&P 500.

Analyst Ratings

This is a summary of recent recommendations and price targets for PetMed Express and Globavend, as reported by MarketBeat.com.

	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
PetMed Express	1	0	0	0	1.00
Globavend	1	0	0	1	2.50

PetMed Express presently has a consensus target price of $3.20, indicating a potential upside of 21.67%. Globavend has a consensus target price of $80.00, indicating a potential upside of 1,490.46%. Given Globavend’s stronger consensus rating and higher possible upside, analysts clearly believe Globavend is more favorable than PetMed Express.

Insider and Institutional Ownership

73.3% of PetMed Express shares are held by institutional investors. 1.1% of PetMed Express shares are held by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company is poised for long-term growth.

Profitability

This table compares PetMed Express and Globavend’s net margins, return on equity and return on assets.

	Net Margins	Return on Equity	Return on Assets
PetMed Express	0.14%	0.37%	0.23%
Globavend	N/A	N/A	N/A

Earnings & Valuation

This table compares PetMed Express and Globavend”s gross revenue, earnings per share and valuation.

	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
PetMed Express	$281.06 million	0.19	-$7.46 million	$0.01	263.00
Globavend	$16.54 million	0.02	$1.34 million	N/A	N/A

Globavend has lower revenue, but higher earnings than PetMed Express.

Summary

PetMed Express beats Globavend on 7 of the 12 factors compared between the two stocks.

About PetMed Express

PetMed Express, Inc., together with its subsidiaries, operates as a pet pharmacy in the United States. The company markets prescription and non-prescription pet medications, health products, and other supplies for dogs, cats, and horses. It offers non-prescription medications and supplies, such as flea and tick control products, bone and joint care products, vitamins, treats, nutritional supplements, hygiene products, and household pet supplies; and prescription medications, including heartworm preventatives, flea and tick preventatives, arthritis, dermatitis, thyroid, diabetes, pain medications, heart/blood pressure, and other specialty medications, as well as generic substitutes. The company also sells food, beds, crates, stairs, and other pet supplies. It sells its products through its Internet website; mobile app; customer support center; and direct mail/print, which includes brochures and postcards. The company was incorporated in 1996 and is headquartered in Delray Beach, Florida.

About Globavend

Globavend Holdings Limited, together with its subsidiaries, provides integrated cross-border logistics services and air freight forwarding services in Hong Kong, Australia, and New Zealand. The company's services include parcel consolidation, air freight forwarding, customs clearance, on-carriage parcel transportation, and delivery. It serves e-commerce merchants and operators of e-commerce platforms. The company was founded in 2016 and is based in Perth, Australia. Globavend Holdings Limited is subsidiary of Globavend Investments Limited.